Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Global Blood Processing Products Market $62.5 Billion by 2029

The global market for blood processing devices and consumables projected to reach $62.5 billion by 2029, expanding at a CAGR of 9.6%, driven by technological advancements, and increasing number of surgical procedures worldwide.

  • Blood transfusion permits increasingly complex medical and surgical interventions to significantly improve the life expectancy and quality of life of patients. The timely availability of safe blood is essential to address the clinical demand that arises in health care facilities to ensure appropriate treatment and minimize preventable mortality.
    • The clinical demand for the total number of units of whole blood and components required to meet all blood transfusions for emergencies and elective procedures at the healthcare facilities has been increasing over time. 
Global Blood Processing Products Market

The availability of safe blood and blood products is a prerequisite for various healthcare services including some surgeries, treatments for cancer and other acute and chronic medical conditions, trauma care, organ transplantation, and childbirths that extend and improve life for millions of patients annually.

  • The requirement for safe and effective blood component processing requires commitment and support by national health authorities for a sustainable, well-organized, nationally coordinated blood transfusion service, with adequate resources and quality system for all areas.
    • The centralization of blood processing and testing within major centers to permit economies of scale by maximizing utilization of personnel and equipment and uniform standards; effective and timely testing of all donated blood to ensure maximum safety and availability of blood components; and promotion of appropriate blood component therapy.
      • Best practices observed in some countries include effective hemovigilance (HV) programs, improved regulatory environment for medical devices, and more-coordinated government support for research and development (R&D).
Blood Processing Products and Consumables Market

The global blood processing products and consumables market report provides market size estimates ($million 2019 to 2029), market share, growth trends and forecast (CAGR% 2023 to 2029).

The global market for blood processing products segmented by device (blood bank freezers, refrigerators, blood cell processors, blood grouping analyzers, blood warmers, hematocrit centrifuges) consumable (blood administration sets, blood bags, blood collection needles, tubes, filters, blood grouping reagents, blood lancets, blood coagulation reagents, blood hematology reagents, microscopic slides, sedimentation tubes, slide stains, and test tube racks), and geography.

  • Based on the broader category, the blood processing devices segment accounted for the largest share of the total market, whereas the blood processing consumables segment expected to witness the slightly fastest growth rate in the near future.
    • Among the blood processing devices, both the blood cell processors and hematocrit centrifuges sub-segments held the majority revenue share of the global market. These sub-segments also anticipated to register the fastest CAGR throughout the forecast period.
      • Hemoglobin and hematocrit along with clinical symptoms of anemia have been the traditional markers used to determine the threshold for transfusion of red blood cells. 
      • In primary healthcare settings, especially in resource-limited settings, macro-hematocrit and micro-hematocrit methods are two low-cost and simple tests for determining RBC in blood.
        • The micro-hematocrit method is more acceptable as it requires less amount of blood, and the testing time is very less in comparison to the macro-hematocrit method.
          • In addition, clinically, hematocrit (HCT) is used to identify anemia and polycythemia along with other parameters (e.g., RBC count, Hb concentration). 
    • Out of the blood processing consumables, the blood bags sub-segment accounted for the largest share of the global blood processing market, while the blood coagulation reagents sub-segment predicted to show the fastest double-digit growth rate over the forecast period.

Market drivers for blood processing devices and consumables

  • Technological advancements such as automated blood collection and processing devices, portable and/or custom-made blood collection and processing devices, 3-D printed blood collection devices, microfluidic blood collection devices, RFID-enabled devices, and robotics in blood processing industry
  • High demand for blood due to increase in the number of surgical procedures
  • Government support and policy initiatives

The global market for blood processing devices is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

  • In the United States, leading trends affecting the blood sector include reduced demand for blood, shrinking profits for blood centers and their suppliers, a shrinking pool of active donors, hospital consolidation, and blood center alliances or consolidation.
    • According to WHO, 91% of the blood collected in high-income countries, 72% of that in middle-income countries and 31% of that in low-income countries is separated into components.
      • Out of the >100 million individual blood components transfused each year worldwide, more than 30 million is in the U.S. alone.
    • In countries with high-level care and treatment, the blood supply should support advanced surgical and medical procedures with specific blood components, while with low-level care, whole blood is often used for the management of more basic transfusion needs such as severe anemia and acute bleeding.
  • In many developing and under-developed countries, there is a widespread shortfall between demand and supply of blood due to several barriers.
    • The major factors are increasing requirement for blood and blood products, poor implementation of voluntary donation and blood safety programs in countries, inadequate voluntary non-remunerated blood donation (VNRBD), suboptimal component separation, inadequate infrastructure, equipment and trained human resources, inappropriate use of blood and blood components, poor quality management systems, poor supply chain management systems, lack of cold chain, wastages and expiry of blood,

The global market blood processing devices research report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.

  • The blood management company, Terumo BCT is a global leader in blood component, therapeutic apheresis, and cellular technologies, with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies.

Major competitors operating in the global blood processing devices market and included in this report are Abbott Laboratories, Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Fresenius Kabi AG, Grifols S.A., Haemonetics Corporation, Immucor, Inc., Macopharma S.A., Roche Holdings AG, Terumo Corporation, and Thermogenesis Corporation.

  • Product
    • Devices
      • Blood Bank Freezers
      • Blood Bank Refrigerators
      • Blood Cell Processors
      • Blood Grouping Analyzers
      • Blood Warmers
      • Hematocrit Centrifuges
    • Consumables
      • Blood Administration Sets
      • Blood Bags
      • Blood Collection Needles
      • Blood Collection Tubes
      • Blood Filters
      • Blood Grouping Reagents
      • Blood Lancets
      • Coagulation Reagents
      • Hematology Reagents
      • Microscopic Slides
      • Sedimentation Tubes
      • Slide Stains
      • Test Tube Racks
      • Vials
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Abbott Laboratories, Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Fresenius Kabi AG
    • Grifols S.A.
    • Haemonetics Corporation
    • Immucor, Inc.
    • Macopharma S.A.
    • Roche Holdings AG
    • Terumo Corporation
    • Thermogenesis Corporation

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com